Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Oct 14, 2011

Premium

Vermillion announced this week that Sandra Gardiner has resigned as vice president and chief financial officer and is leaving the company to take a job with an undisclosed firm in the San Francisco Bay Area.

The company also appointed Eric Schoen as chief accounting officer. Previously Schoen was corporate controller at Vermillion. Before that he was revenue controller for Borland Software.


Hybrigenics has appointed Alain Munoz to its board of directors. Munoz replaces Bernhard Ehmer, president of ImClone Systems, and will chair the company's clinical advisory board.

Munoz is a board member at several biotech companies including Vivalis, Novagali Pharma, and Zealand Pharma. Previously he was R&D vice president at the Sanofi Group and senior vice president of the pharmaceutical division at Fournier.


Riccardo Pigliucci has joined Bioscale's board of directors.

Pigliucci is the former chief operating operator of PerkinElmer as well as CEO of Life Sciences International and Discovery Partners International. He was also lead director on the board of Dionex, which was recently purchased by Thermo Fisher Scientific.


Protea Biosciences has hired Alessandro Baldi as vice president and general manager.

Previously Baldi was senior director of PerkinElmer's mass spectrometry business.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.